Oracea (Doxycycline)

Doxycycline binds to the bacterial 30S ribosomal subunit, inhibiting protein synthesis. At the low daily doses used for rosacea, it also exerts anti‑inflammatory effects by suppressing matrix metalloproteinases and cytokine production, which reduces skin inflammation and vascular dilation.

The specific dose of Oracea is determined by the prescribing clinician based on the patient’s condition, age, renal function and other factors. Healthcare professionals follow the product label and clinical guidelines to select the appropriate regimen.

Doxycycline is generally avoided in pregnancy because of potential risks to the fetus, and it is excreted in breast milk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative therapies with their healthcare provider.

To request Oracea, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oracea’s low‑dose doxycycline offers both antibacterial and anti‑inflammatory actions, distinguishing it from topical agents and higher‑dose tetracyclines such as minocycline. Compared with topical metronidazole, Oracea provides systemic coverage and may be more convenient for patients with widespread facial involvement.

Oracea should be stored at room temperature, below 25 °C, in its original blister pack or bottle. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability throughout its shelf life.

Oracea is taken orally with a full glass of water. It can be taken with or without food, but patients should avoid taking it simultaneously with antacids or calcium‑rich foods, as these can interfere with absorption.

Patients should be alert for signs of severe allergic reaction such as swelling, difficulty breathing, or rash, as well as rare but serious skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Intracranial hypertension symptoms, including severe headache or visual changes, also require immediate medical attention.

Oracea is contraindicated in individuals with known hypersensitivity to doxycycline or other tetracyclines, children under eight years of age, pregnant women, and patients with severe hepatic impairment. Those with a history of intracranial hypertension should also avoid this medication.